Evidence map›Paper›PMID 36028192›Full record

ArticleContemporary clinical trials2022

The design of the Dashboard Activated Services and Telehealth for Heart Failure (DASH-HF) study: A pragmatic quality improvement randomized implementation trial for patients with heart failure with reduced ejection fraction.

Aradhana Verma, Gregg C Fonarow, Jeffrey J Hsu, Cynthia A Jackevicius, Freny Vaghaiwalla Mody, Omid Amidi, Sarah Goldberg, Deepti Upparapalli, Kleanthis Theodoropoulos, Stephanie Gregorio and 4 more

Registry-linked trialOpen access · greenAbstract readClinical Trial Protocol
In one paragraph

Article in Contemporary clinical trials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05001165 (Dashboard Activated Services and Tele-Health for Heart Failure), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05001165 nacompletednot on this map

Dashboard Activated Services and Tele-Health for Heart Failure

TypeinterventionalSponsorVA Greater Los Angeles Healthcare SystemRan2021 to 2022Enrolled300ConditionsHeart Failure With Reduced Ejection FractionArmsProactive Panel Management Clinics for HFrEF
3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Aradhana VermaDepartment of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States of America.
Gregg C FonarowDivision of Cardiology, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States of America.
Jeffrey J HsuDivision of Cardiology, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States of America; Division of Cardiology, VA Greater Los Angeles Healthcare System, Los Angeles, CA, United States of America.
Cynthia A JackeviciusDepartment of Pharmacy Practice and Administration, Western University of Health Sciences, Pomona, CA, Department of Pharmacy, VA Greater Los Angeles Healthcare System, ICES, Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada.
Freny Vaghaiwalla ModyDivision of Cardiology, VA Greater Los Angeles Healthcare System, Los Angeles, CA, United States of America.
Omid AmidiDivision of Cardiology, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States of America.
Sarah GoldbergDivision of Cardiology, VA Greater Los Angeles Healthcare System, Los Angeles, CA, United States of America.
Deepti UpparapalliDivision of Cardiology, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States of America.
Kleanthis TheodoropoulosDivision of Cardiology, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States of America.
Stephanie GregorioDepartment of Pharmacy, VA Greater Los Angeles Healthcare System, Los Angeles, CA, United States of America.
Donald S ChangDivision of Cardiology, VA Greater Los Angeles Healthcare System, Los Angeles, CA, United States of America.
Kristina BostromDivision of Cardiology, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States of America; Division of Cardiology, VA Greater Los Angeles Healthcare System, Los Angeles, CA, United States of America.
Andrew D AlthouseDepartment of Medicine, University of Pittsburgh, Pittsburgh, PA, United States of America.
Boback ZiaeianDivision of Cardiology, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States of America; Division of Cardiology, VA Greater Los Angeles Healthcare System, Los Angeles, CA, United States of America. Electronic address: BZiaeian@mednet.ucla.edu.
University of California, Los Angeles · USVA Greater Los Angeles Healthcare System · USUniversity of Pittsburgh · USWestern University of Health Sciences · US

Funding

The Effect of Nanoparticle Encapsulated Resveratrol on Treatment of PeriodontitisKL2TR001882 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Elizabeta Nemeth · 2016 to 2026
$13.1M
NCATS NIH HHS KL2 TR001882
6 · The paper itself

Abstract

backgroundGaps in the receipt and dosing of guideline-directed medical therapy (GDMT) persist for patients with heart failure with reduced ejection fraction (HFrEF) [1]. In 2020, the Veterans Affairs (VA) developed a heart failure (HF) specific population dashboard to monitor care quality and performance on standard HFrEF performance measures [2].

methodsThe Dashboard Activated Services and Telehealth for HF (DASH-HF) study is a pragmatic randomized quality improvement study designed to evaluate the utility of proactive population management clinics using the VA's HF dashboard to optimize GDMT for patients with HFrEF. Panel management telemedicine clinics incorporated multidisciplinary clinicians to perform chart review and impromptu telephone encounters to evaluate current HFrEF management and opportunities to optimize GDMT. The study will evaluate the efficacy of proactive panel management to usual care at 6 months as quantified by the GDMT optimization potential score. Secondary outcomes include hospitalizations, mortality, and clinician time per intervention. The study completed enrollment and randomization of 300 participants. The intervention was performed from September to December 2021.

conclusionDASH-HF will contribute to the literature by evaluating use of the existing VA dashboard to identify HF patients with the lowest adherence to GDMT and proactively target this group for the intervention. REGISTRATION: https://clinicaltrials.gov/. Unique identifier: NCT05001165.

Indexed as

Heart FailureTelemedicineHospitalizationHumansPragmatic Clinical Trials as TopicQuality ImprovementRandomized Controlled Trials as TopicStroke VolumeGuideline-directed medical treatmentHeart failureQuality improvementTelemedicine

Identifiers

PMID36028192
PMCPMC9635621
OpenAlexW4292840424

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.